{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T13:41:35Z","timestamp":1792676495189,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T00:00:00Z","timestamp":1704240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T00:00:00Z","timestamp":1704240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"crossref","award":["CM20\/00138"],"award-info":[{"award-number":["CM20\/00138"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    SARS-CoV-2 reinfections have been frequent, even among those vaccinated. The aim of this study is to know if hybrid immunity (infection\u2009+\u2009vaccination) is affected by the moment of vaccination and number of\u00a0doses received. We conducted a retrospective study in 746 patients with a history of COVID-19 reinfection and recovered the dates of infection and reinfection and vaccination status (date and number of doses). To assess differences in the time to reinfection(t\n                    <jats:sub>RI<\/jats:sub>\n                    ) between unvaccinated, vaccinated before 6\u00a0months, and later; and comparing one, two or three doses (incomplete, complete and booster regime) we performed the log-rank test of the cumulative incidence calculated as 1 minus the Kaplan\u2013Meier estimator. Also, an adjusted Cox-regression was performed to evaluate the risk of reinfection in all\u00a0groups.\u00a0The t\n                    <jats:sub>RI<\/jats:sub>\n                    was significantly higher in those vaccinated vs. non-vaccinated (p\u2009&lt;\u20090.001). However, an early incomplete regime protects similar time than not receiving a vaccine. Vaccination before 6\u00a0months after infection showed a lower t\n                    <jats:sub>RI<\/jats:sub>\n                    compared to those vaccinated later with the same regime (adj-p\u2009&lt;\u20090.001). Actually, early vaccination with complete and booster regimes provided lower length of protection compared to vaccinating later with incomplete and complete regime, respectively. Vaccination with complete and booster regimes significantly increases the t\n                    <jats:sub>RI<\/jats:sub>\n                    (adj-p\u2009&lt;\u20090.001). Vaccination increases the time it takes for a person to become reinfected with SARS-CoV-2. Increasing the time from infection to vaccination increases the time in which a person could be reinfected\u00a0and reduces\u00a0the risk of reinfection, especially in complete and booster regimes.\u00a0Those results emphasize the role of vaccines and boosters during the pandemic and can guide strategies on future vaccination policy.\n                  <\/jats:p>","DOI":"10.1038\/s41598-023-50335-6","type":"journal-article","created":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T11:03:36Z","timestamp":1704279816000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Impact on the time elapsed since SARS-CoV-2 infection, vaccination history, and number of doses, on protection against reinfection"],"prefix":"10.1038","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6929-8453","authenticated-orcid":false,"given":"Laura","family":"S\u00e1nchez-de Prada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Mar\u00eda","family":"Mart\u00ednez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bel\u00e9n","family":"Gonz\u00e1lez-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Guti\u00e9rrez-Ballesteros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3745-3201","authenticated-orcid":false,"given":"Silvia","family":"Rojo-Rello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonsoles","family":"Garcinu\u00f1o-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1315-4386","authenticated-orcid":false,"given":"Alejandro","family":"\u00c1lvaro-Meca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4117-1186","authenticated-orcid":false,"given":"Ra\u00fal","family":"Ortiz De Lejarazu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4725-6663","authenticated-orcid":false,"given":"Iv\u00e1n","family":"Sanz-Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5357-6340","authenticated-orcid":false,"given":"Jos\u00e9 M.","family":"Eiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,3]]},"reference":[{"key":"50335_CR1","unstructured":"World Health Organisation (WHO). WHO Coronavirus (COVID-19) Dashboard [Internet] (2023, accessed 10 May 2023). https:\/\/covid19.who.int\/."},{"key":"50335_CR2","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/S0140-6736(21)00432-3","volume":"397","author":"M Voysey","year":"2021","unstructured":"Voysey, M. et al. Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: A pooled analysis of four randomised trials. The Lancet 397, 881\u2013891 (2021).","journal-title":"The Lancet"},{"key":"50335_CR3","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","volume":"384","author":"LR Baden","year":"2021","unstructured":"Baden, L. R. et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. New Engl. J. Med. 384, 403\u2013416 (2021).","journal-title":"New Engl. J. Med."},{"key":"50335_CR4","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"FP Polack","year":"2020","unstructured":"Polack, F. P. et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. New Engl. J. Med. 383, 2603\u20132615 (2020).","journal-title":"New Engl. J. Med."},{"key":"50335_CR5","doi-asserted-by":"publisher","first-page":"e120","DOI":"10.1016\/S2213-2600(21)00495-1","volume":"9","author":"T Kirby","year":"2021","unstructured":"Kirby, T. Has Spain reached herd immunity?. Lancet Respir Med. 9, e120 (2021).","journal-title":"Lancet Respir Med."},{"key":"50335_CR6","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s00705-022-05365-2","volume":"167","author":"M Salehi-Vaziri","year":"2022","unstructured":"Salehi-Vaziri, M. et al. The ins and outs of SARS-CoV-2 variants of concern (VOCs). Arch. Virol. 167, 327\u2013344 (2022).","journal-title":"Arch. Virol."},{"key":"50335_CR7","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.3201\/eid2704.210183","volume":"27","author":"F Maggi","year":"2021","unstructured":"Maggi, F. et al. Imported SARS-CoV-2 variant P.1 in traveler returning from Brazil to Italy. Emerg. Infect. Dis. 27, 1249\u20131251 (2021).","journal-title":"Emerg. Infect. Dis."},{"key":"50335_CR8","doi-asserted-by":"publisher","first-page":"e1010022","DOI":"10.1371\/journal.ppat.1010022","volume":"17","author":"C Davis","year":"2021","unstructured":"Davis, C. et al. Reduced neutralisation of the Delta (B.1.617.2) SARS-CoV-2 variant of concern following vaccination. Lee B, editor. PLoS Pathog. 17, e1010022 (2021).","journal-title":"PLoS Pathog."},{"key":"50335_CR9","first-page":"8019","volume":"25","author":"S Kannan","year":"2021","unstructured":"Kannan, S., Shaik, S. A. P. & Sheeza, A. Omicron (B.1.1.529)\u2014variant of concern\u2014molecular profile and epidemiology: A mini review. Eur. Rev. Med. Pharmacol. Sci. 25, 8019\u20138022 (2021).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"50335_CR10","first-page":"7","volume":"2022","author":"TA Bates","year":"2022","unstructured":"Bates, T. A. et al. Vaccination before or after SARS-CoV-2 infection leads to robust humoral response and antibodies that effectively neutralize variants. Sci. Immunol. 2022, 7 (2022).","journal-title":"Sci. Immunol."},{"key":"50335_CR11","first-page":"1","volume":"2","author":"X Chen","year":"2021","unstructured":"Chen, X. et al. Neutralizing antibodies against SARS-CoV-2 variants induced by natural infection or vaccination: A systematic review and individual data meta-analysis. SSRN Electron. J. 2, 1\u20139 (2021).","journal-title":"SSRN Electron. J."},{"key":"50335_CR12","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.1080\/21645515.2020.1830683","volume":"16","author":"F Nainu","year":"2020","unstructured":"Nainu, F. et al. SARS-CoV-2 reinfection and implications for vaccine development. Hum. Vacc. Immunother. 16, 3061\u20133073 (2020).","journal-title":"Hum. Vacc. Immunother."},{"key":"50335_CR13","doi-asserted-by":"publisher","first-page":"102792","DOI":"10.1016\/j.jaut.2021.102792","volume":"127","author":"A Haque","year":"2022","unstructured":"Haque, A. & Pant, A. B. Mitigating Covid-19 in the face of emerging virus variants, breakthrough infections and vaccine hesitancy. J. Autoimmun. 127, 102792 (2022).","journal-title":"J. Autoimmun."},{"key":"50335_CR14","unstructured":"World Health Organisation (WHO). Fact sheet: Global Influenza Surveillance and Response System (GISRS) [Internet] (2022, accessed 24 Oct 2023). https:\/\/www.who.int\/initiatives\/global-influenza-surveillance-and-response-system."},{"key":"50335_CR15","unstructured":"National Center for Immunization and Respiratory Diseases(NCIRD), Division of Viral Diseases. Investigative Criteria for Suspected Cases of SARS-CoV-2 Reinfection [Internet] (2022, accessed 31 Jan 2022). https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/php\/invest-criteria.html."},{"key":"50335_CR16","unstructured":"Grupo de Trabajo T\u00e9cnico de Vacunaci\u00f3n COVID-19 de la P de P y R de VacunacionesM de Sanidad. Principales cambios en las Actualizaciones de la Estrategia de Vacunaci\u00f3n frente a COVID-19 en Espa\u00f1a. Actualizaciones 1\u201310. [Internet] (2022, accessed 31 Jan 2022). https:\/\/www.sanidad.gob.es\/profesionales\/saludPublica\/prevPromocion\/vacunaciones\/covid19\/Actualizaciones_EstrategiaVacunacionCOVID-19.htm."},{"key":"50335_CR17","doi-asserted-by":"publisher","first-page":"11001","DOI":"10.3390\/ijerph182011001","volume":"18","author":"L Lo Muzio","year":"2021","unstructured":"Lo Muzio, L., Ambosino, M., Lo Muzio, E. & Quadri, M. F. A. SARS-CoV-2 reinfection is a new challenge for the effectiveness of global vaccination campaign: A systematic review of cases reported in literature. Int. J. Environ. Res. Public Health 18, 11001 (2021).","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"50335_CR18","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1136\/jim-2021-001853","volume":"69","author":"J Wang","year":"2021","unstructured":"Wang, J., Kaperak, C., Sato, T. & Sakuraba, A. Covid-19 reinfection: A rapid systematic review of case reports and case series. J. Investig. Med. 69, 1253\u20131255 (2021).","journal-title":"J. Investig. Med."},{"key":"50335_CR19","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1001\/jamainternmed.2021.2959","volume":"181","author":"J Vitale","year":"2021","unstructured":"Vitale, J. et al. Assessment of SARS-CoV-2 reinfection 1 year after primary infection in a population in Lombardy, Italy. JAMA Intern. Med. 181, 1407\u20131408 (2021).","journal-title":"JAMA Intern. Med."},{"key":"50335_CR20","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/s41586-021-03696-9","volume":"595","author":"Z Wang","year":"2021","unstructured":"Wang, Z. et al. Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection. Nature 595, 426\u2013431 (2021).","journal-title":"Nature"},{"key":"50335_CR21","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1001\/jama.2021.22898","volume":"327","author":"TA Bates","year":"2022","unstructured":"Bates, T. A. et al. Antibody response and variant cross-neutralization after SARS-CoV-2 breakthrough infection. JAMA 327, 179 (2022).","journal-title":"JAMA"},{"key":"50335_CR22","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1016\/j.cell.2022.03.018","volume":"185","author":"LB Rodda","year":"2022","unstructured":"Rodda, L. B. et al. Imprinted SARS-CoV-2-specific memory lymphocytes define hybrid immunity. Cell 185, 1588\u20131601 (2022).","journal-title":"Cell"},{"key":"50335_CR23","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1177\/01632787211047932","volume":"44","author":"N Kojima","year":"2021","unstructured":"Kojima, N., Shrestha, N. K. & Klausner, J. D. A Systematic review of the protective effect of prior SARS-CoV-2 infection on repeat infection. Eval. Health Prof. 44, 327\u2013332 (2021).","journal-title":"Eval. Health Prof."},{"key":"50335_CR24","doi-asserted-by":"publisher","first-page":"112911","DOI":"10.1016\/j.envres.2022.112911","volume":"209","author":"S Pilz","year":"2022","unstructured":"Pilz, S., Theiler-Schwetz, V., Trummer, C., Krause, R. & Ioannidis, J. P. A. SARS-CoV-2 reinfections: Overview of efficacy and duration of natural and hybrid immunity. Environ. Res. 209, 112911 (2022).","journal-title":"Environ. Res."},{"key":"50335_CR25","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1056\/NEJMc2101667","volume":"384","author":"F Krammer","year":"2021","unstructured":"Krammer, F. et al. Antibody responses in seropositive persons after a single dose of SARS-CoV-2 mRNA vaccine. New Engl. J. Med. 384, 1372\u20131374 (2021).","journal-title":"New Engl. J. Med."},{"key":"50335_CR26","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1038\/s41591-021-01325-6","volume":"27","author":"JE Ebinger","year":"2021","unstructured":"Ebinger, J. E. et al. Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2. Nat. Med. 27, 981\u2013984 (2021).","journal-title":"Nat. Med."},{"key":"50335_CR27","first-page":"6","volume":"2021","author":"RR Goel","year":"2021","unstructured":"Goel, R. R. et al. Distinct antibody and memory B cell responses in SARS-CoV-2 na\u00efve and recovered individuals after mRNA vaccination. Sci. Immunol. 2021, 6 (2021).","journal-title":"Sci. Immunol."},{"key":"50335_CR28","unstructured":"Clare Roth. COVID: Do multiple boosters \u201cexhaust\u201d our immune response? [Internet]. Deutsche Welle-Science. (2022, accessed 8 Feb 2022). https:\/\/p.dw.com\/p\/45dDT."},{"key":"50335_CR29","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.chom.2022.11.016","volume":"31","author":"DM Morens","year":"2023","unstructured":"Morens, D. M., Taubenberger, J. K. & Fauci, A. S. Rethinking next-generation vaccines for coronaviruses, influenzaviruses, and other respiratory viruses. Cell Host Microbe. 31, 146\u2013157 (2023).","journal-title":"Cell Host Microbe."},{"key":"50335_CR30","first-page":"13","volume":"2022","author":"X He","year":"2022","unstructured":"He, X., Su, J., Ma, Y., Zhang, W. & Tang, S. A comprehensive analysis of the efficacy and effectiveness of COVID-19 vaccines. Front. Immunol. 2022, 13 (2022).","journal-title":"Front. Immunol."},{"key":"50335_CR31","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1093\/infdis\/jix282","volume":"216","author":"MK Andrew","year":"2017","unstructured":"Andrew, M. K. et al. The importance of frailty in the assessment of influenza vaccine effectiveness against influenza-related hospitalization in elderly people. J. Infect. Dis. 216, 405\u2013414 (2017).","journal-title":"J. Infect. Dis."},{"key":"50335_CR32","unstructured":"Centro de Coordinaci\u00f3n de Alertas y Emergencias Sanitarias. Evaluaci\u00f3n R\u00e1pida de Riesgo de Variantes de SARS-CoV-2 en Espa\u00f1a: linajes BA.2.12.1, BA.4 y BA.5 de \u00d3micron. 11a Actualizaci\u00f3n. [Internet]. 2022. https:\/\/www.sanidad.gob.es\/profesionales\/saludPublica\/ccayes\/alertasActual\/nCov\/documentos\/20220628-ERR.pdf."},{"key":"50335_CR33","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1056\/NEJMoa2119451","volume":"386","author":"N Andrews","year":"2022","unstructured":"Andrews, N. et al. Covid-19 vaccine effectiveness against the omicron (B.1.1.529) Variant. New Engl. J. Med. 386, 1532\u20131546 (2022).","journal-title":"New Engl. J. Med."},{"key":"50335_CR34","first-page":"572","volume":"104","author":"T Francis","year":"1960","unstructured":"Francis, T. On the doctrine of original antigenic sin. Proc. Am. Philos. Soc. 104, 572\u2013578 (1960).","journal-title":"Proc. Am. Philos. Soc."},{"key":"50335_CR35","doi-asserted-by":"publisher","first-page":"7120","DOI":"10.1038\/s41467-022-34400-8","volume":"13","author":"B Ju","year":"2022","unstructured":"Ju, B. et al. Antigenic sin of wild-type SARS-CoV-2 vaccine shapes poor cross-neutralization of BA.4\/5\/2.75 subvariants in BA.2 breakthrough infections. Nat. Commun. 13, 7120 (2022).","journal-title":"Nat. Commun."},{"key":"50335_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/CMR.00084-18","volume":"32","author":"P Zimmermann","year":"2019","unstructured":"Zimmermann, P. & Curtis, N. Factors that influence the immune response to vaccination. Clin. Microbiol. Rev. 32, 1\u201350 (2019).","journal-title":"Clin. Microbiol. Rev."},{"key":"50335_CR37","doi-asserted-by":"publisher","first-page":"14001","DOI":"10.1073\/pnas.96.24.14001","volume":"96","author":"DJ Smith","year":"1999","unstructured":"Smith, D. J., Forrest, S., Ackley, D. H. & Perelson, A. S. Variable efficacy of repeated annual influenza vaccination. Proc. Natl. Acad. Sci. U. S. A. 96, 14001\u201314006 (1999).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-50335-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-50335-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-50335-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T11:06:10Z","timestamp":1704279970000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-50335-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,3]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["50335"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-50335-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3008644\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,3]]},"assertion":[{"value":"1 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"353"}}